期刊文献+

亚砷酸联合反应停治疗造血干细胞移植后复发的多发性骨髓瘤1例

下载PDF
导出
出处 《临床血液学杂志》 CAS 2004年第2期120-120,共1页 Journal of Clinical Hematology
  • 相关文献

参考文献3

二级参考文献10

  • 1[1]Singhal S,Mehta J,Desikan R,et al.Anti-tumor activity of thalidomide in refractory multiple myeloma.N Eng J Med,1999,341:1565-1571.
  • 2[2]Parman T,Wiley MJ,Wells PG,et al.Free radial-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity.Nature Medicine,1999,5:582-585.
  • 3[3]Geitz H,Handt S,Zwingenger K,Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade.Immunopharmacology,1996,32:213-221.
  • 4[4]Corral LG,Haslett PAJ,Muller GW,et al.Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-α. J Immunol,1999,163:380-386.
  • 5[5]Vacca A,Ribatti D,Presta M,et al.Bone marrow neovascularization,plasma cell angiogenic potential,and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma.Blood,1999,13:3064-3073.
  • 6[6]Bellamy W,Richter L,Frutigar Y,et al.Expression of vasular endothelial growth factor and its receptor in hematological malignancies.Cancer Res,1999,59:728-733.
  • 7[7]Haslett PAJ,Corral LG,Albert M,et al.Thalidomide costimulates primary human T lymphocytes,preferentially inducing proliferation,cytokine production,and cytotoxic responses in the CD8+ subset.J Exp Med,1998,187:1885-1892.
  • 8[8]Juliusson G,Celsing F,Turesson Ι,et al.Frequent good partial remission from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma.Br J Haematol,2000,109:89-96.
  • 9[9]Kneller A,Raanani P,Hardan I,et al.Therapy with thalidomide in refractory multiple myeloma-the revival of an old drug.Br J Haematol 2000;108:391-393.
  • 10李富君,孙贵范.砷对小鼠心脏某些生化功能的影响[J].卫生毒理学杂志,1998,12(3):143-145. 被引量:3

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部